Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 5
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Patel, Pragna Bush, Timothy Kojic, E. Milu Overton, Edgar T. Henry, Keith Önen, Nur Rhame, Frank Conley, Lois Brooks, John T. and Fry, Alicia 2016. Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010–2011. AIDS Research and Human Retroviruses,

    Xu, Cuiling Chan, Kwok-Hung Tsang, Tim K. Fang, Vicky J. Fung, Rita O. P. Ip, Dennis K. M. Cauchemez, Simon Leung, Gabriel M. Peiris, J. S. Malik and Cowling, Benjamin J. 2015. Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households. American Journal of Epidemiology, Vol. 182, Issue. 8, p. 705.

    Fielding, James E. Kelly, Heath A. Mercer, Geoffry N. and Glass, Kathryn 2014. Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age. Influenza and Other Respiratory Viruses, Vol. 8, Issue. 2, p. 142.

    Wu, Peng Cowling, Benjamin J. Wu, Joseph T. Lau, Eric H. Y. Ip, Dennis K. M. and Nishiura, Hiroshi 2013. The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong. Influenza and Other Respiratory Viruses, Vol. 7, Issue. 3, p. 367.

    Lee, N. and Ison, M. G. 2012. Editorial Commentary: "Late" Treatment With Neuraminidase Inhibitors for Severely Ill Patients With Influenza: Better Late Than Never?. Clinical Infectious Diseases, Vol. 55, Issue. 9, p. 1205.


Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus

  • Y. H. LEUNG (a1), W. L. LIM (a2), M. H. WONG (a1) and S. K. CHUANG (a1)
  • DOI:
  • Published online: 29 July 2011

During the early phase of the influenza pandemic in 2009, all cases of laboratory-confirmed pandemic (H1N1) 2009 (pH1N1) infection required compulsory isolation in hospital. These cases were offered oseltamivir treatment and only allowed to be discharged from the hospital when three consecutive respiratory specimens were negative for the virus by reverse transcription–polymerase chain reaction (RT–PCR). We reviewed the case records of these patients to assess the viral shedding kinetics of the pH1N1 virus. We defined viral shedding duration as the interval from illness onset date to the date of collection of the last positive specimen from the patients. Fifty-six patients were included in the study, of whom 96% received oseltamivir. The median viral shedding duration of pH1N1 virus by viral culture and RT–PCR were 3 days and 4 days, respectively. Patients who started oseltamivir treatment >48 h after onset had a significantly longer median viral shedding duration by viral culture than those who started treatment within 48 h of onset (4 days vs. 2 days, P=0·014).

Corresponding author
*Author for correspondence: Y. H. Leung, Field Epidemiology Training Programme, Centre for Health Protection, Department of Health, Room 325, 147C Argyle Street, Kowloon, Hong Kong. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

4.RB Couch , JA Kasel . Influenza. In: EH Lennette , DA Lennette , ET Lennette , eds. Diagnostic Procedures for Viral, Rckettsial and Chlamydial infections, 7th edn.Washington: American Public Health Association, 1995, pp. 431446.

6.LM Ling , Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clinical Infectious Diseases 2010; 50: 963969.

7.CT Witkop , Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. American Journal of Preventive Medicine 2010; 38: 121126.

8.FY Aoki , Early administration of oral oseltamivir increases the benefits of influenza treatment. Journal of Antimicrobial Chemotherapy 2003; 51: 123129.

9.N Kawai , Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002–2003 influenza season. Clinical Infectious Diseases 2005; 40: 13091316.

10.B Cao , Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. New England Journal of Medicine 2009; 361: 25072517.

11.H Yu , Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. British Medical Journal 2010; 341: c4779.

12.CC Li , Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerging Infectious Diseases 2010; 16: 12651272.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *